The influence of metabolic syndrome and its components on the development of nephrolithiasis

by Carter Boyd, Kyle Wood, Dustin Whitaker, Dean G. Assimos
Published 2018-10-01

Repetitive ureteral stenting for management of transplant graft ureteral obstruction

by Lester S. Borden Jr, Vernon M. Pais Jr, Dean G. Assimos
Published 2006-04-01

Glyoxal Formation and Its Role in Endogenous Oxalate Synthesis

by Jessica N. Lange, Kyle D. Wood, John Knight, Dean G. Assimos, Ross P. Holmes
Published 2012-01-01

Is There an Association between Childhood Obesity and Pediatric Kidney Stone Disease? A Literature Review

by Henry J. Paiste, Luke Moradi, Dean G. Assimos, Kyle D. Wood, Pankaj P. Dangle
Published 2021-07-01

Dietary Oxalate Loading Impacts Monocyte Metabolism and Inflammatory Signaling in Humans

by Parveen Kumar, Mikita Patel, Robert A. Oster, Vidhush Yarlagadda, Adam Ambrosetti, Dean G. Assimos, Tanecia Mitchell
Published 2021-02-01

Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line

by Mikita Patel, Vidhush Yarlagadda, Oreoluwa Adedoyin, Vikram Saini, Dean G. Assimos, Ross P. Holmes, Tanecia Mitchell
Published 2018-05-01

Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion

by Joseph J. Crivelli, Tanecia Mitchell, John Knight, Kyle D. Wood, Dean G. Assimos, Ross P. Holmes, Sonia Fargue
Published 2021-12-01

ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

by Nicholas G. Zaorsky, MD, Timothy N. Showalter, MD MPH, Gary A. Ezzell, PhD, Paul L. Nguyen, MD, Dean G. Assimos, MD, Anthony V. D'Amico, MD PhD, Alexander R. Gottschalk, MD PhD, Gary S. Gustafson, MD, Sameer R. Keole, MD, Stanley L. Liauw, MD, Shane Lloyd, MD, Patrick W. McLaughlin, MD, Benjamin Movsas, MD, Bradley R. Prestidge, MD MS, Al V. Taira, MD, Neha Vapiwala, MD, Brian J. Davis, MD PhD
Published 2017-01-01

ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II

by Nicholas G. Zaorsky, MD, Timothy N. Showalter, MD, MPH, Gary A. Ezzell, PhD, Paul L. Nguyen, MD, Dean G. Assimos, MD, Anthony V. D'Amico, MD, PhD, Alexander R. Gottschalk, MD, PhD, Gary S. Gustafson, MD, Sameer R. Keole, MD, Stanley L. Liauw, MD, Shane Lloyd, MD, Patrick W. McLaughlin, MD, Benjamin Movsas, MD, Bradley R. Prestidge, MD, MS, Al V. Taira, MD, Neha Vapiwala, MD, Brian J. Davis, MD, PhD
Published 2017-07-01